Literature DB >> 11560970

Targeting the epidermal growth factor receptor: a clinical reality.

J Baselga1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11560970

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  17 in total

1.  Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor.

Authors:  Yi Peter Hu; Sandip B Patil; Michelle Panasiewicz; Wenhui Li; Jennie Hauser; Lisa E Humphrey; Michael G Brattain
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

2.  Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Authors:  Alessandro D Santin; Michael W Sill; D Scott McMeekin; Mario M Leitao; Jubilee Brown; Gregory P Sutton; Linda Van Le; Patricia Griffin; Cecelia H Boardman
Journal:  Gynecol Oncol       Date:  2011-09       Impact factor: 5.482

3.  Genistein-induced G2/M cell cycle arrest of human intestinal colon cancer Caco-2 cells is associated with Cyclin B1 and Chk2 down-regulation.

Authors:  Junkyu Han; Yui Kurita; Hiroko Isoda
Journal:  Cytotechnology       Date:  2013-06-21       Impact factor: 2.058

4.  A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma.

Authors:  Wayne L Furman; Lisa M McGregor; M Beth McCarville; Mihaela Onciu; Andrew M Davidoff; Sandy Kovach; Dana Hawkins; Valerie McPherson; Peter J Houghton; Catherine A Billups; Jianrong Wu; Clinton F Stewart; Victor M Santana
Journal:  Invest New Drugs       Date:  2011-07-28       Impact factor: 3.850

Review 5.  Clinical management of advanced gastric cancer: the role of new molecular drugs.

Authors:  Ferdinando De Vita; Natale Di Martino; Alessio Fabozzi; Maria Maddalena Laterza; Jole Ventriglia; Beatrice Savastano; Angelica Petrillo; Valentina Gambardella; Vincenzo Sforza; Luigi Marano; Annamaria Auricchio; Gennaro Galizia; Fortunato Ciardiello; Michele Orditura
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 6.  Targeting epidermal growth factor receptor in lung cancer.

Authors:  José Baselga; Joan Albanell
Journal:  Curr Oncol Rep       Date:  2002-07       Impact factor: 5.075

7.  Rational use of cetuximab in the treatment of advanced non-small cell lung cancer.

Authors:  Charu Aggarwal; Hossein Borghaei
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

Review 8.  Present and future evolution of advanced breast cancer therapy.

Authors:  Ricardo H Alvarez
Journal:  Breast Cancer Res       Date:  2010-10-22       Impact factor: 6.466

9.  A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor.

Authors:  Achim A Jungbluth; Elisabeth Stockert; H J Su Huang; Vincent P Collins; Keren Coplan; Kristin Iversen; Denise Kolb; Terrance J Johns; Andrew M Scott; William J Gullick; Gerd Ritter; Leonard Cohen; Matthew J Scanlan; Webster K Cavenee; Lloyd J Old; Webster K Cavanee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

10.  Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab.

Authors:  George P Kim; Axel Grothey
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.